BioNexus Gene Lab Corp — Quarterly Financial Statistics (NASDAQ:BGLC)

Financials

Cash from operating activities -1.46 M78.2 K-824.07 K-737.91 K-1.24 M -2.72 M Cash from investing activities -142.92 K554.4 K-15.65 K-28.53 K994.65 K 1.5 M Cash from financing activities -203.96 K-1 387-860-1 03034.19 K 30.91 K Free cash flow -1.65 M74.18 K-833.12 K-759.37 K-1.24 M -2.76 M

ニュース

BioNexus Gene LabがFidelionに最高商業責任者を任命

BioNexus Gene Lab appoints commercial officer at Fidelion

バイオネクサス・ジーン・ラボ、フィデリオン・ダイアグノスティクスと戦略的取引を完了

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics

バイオネクサス・ジーン・ラボ、5億ドルの株式ファシリティ確保後に株価下落

BioNexus Gene Lab stock falls after securing $500M equity facility

BioNexus Gene Lab secures $500 million equity purchase agreement

バイオネクサス・ジーン・ラボの株価、5億ドルの資金調達施設確保で上昇

BioNexus Gene Lab stock climbs after securing $500 million equity facility

BioNexus Gene Lab、液体生検プラットフォームの商業化に向けパートナーシップを締結

BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform

バイオネクサス・ジーン・ラボの株価、MRD検査の戦略的提携で急騰